In human CRC patients, IL-23p19 mRNA and protein expression levels were found to be significantly increased in the tumor tissue compared to adjacent tumor-free colon tissue [76,123], and individuals with elevated IL-23p19 mRNA expression showed lower disease-free survival rates [124]. The gene discussed is IL23A; the disease is colorectal carcinoma.